Paul Bollyky, Professor and Division Chief, Division of Infectious Diseases & Geographic Medicine at Stanford University, shared a post on LinkedIn:
“Good news! The NIH and NIAID have created the Centers for Accelerating Phage Therapy to Combat ESKAPE Pathogens (CAPT-CEP) and have funded three centers at Stanford, The University of Pittsburgh, and the Gladstone Institute at UCSF.
The Center for Phage Pharmaceuticals (Phage Pharm) here at Stanford is a collaboration to develop tools for phage delivery and pharmacology together with our collaborators Kathy Ferrara, Carlos Milla, Jess Sacher, Ann Van Haney, Adam Frymoyer, Nick Smith (U of Buffalo), and Susan Birket (UAB).
So excited to work on this together!